Tag: GCP compliance

Communicating Estimand Choices to Sites, Investigators and Regulators

Posted on By digi

Communicating Estimand Choices to Sites, Investigators and Regulators In the rapidly evolving landscape of clinical trials, the selection and communication of estimands have become increasingly essential. Estimands serve as a bridge between the clinical question of interest and the statistical analysis, particularly in the context of handling intercurrent events. This comprehensive tutorial aims to guide…

Read More “Communicating Estimand Choices to Sites, Investigators and Regulators” »

Estimands & Handling Intercurrent Events

Regulatory Guidance Trends for DCT and Remote Site Oversight

Posted on By digi

Regulatory Guidance Trends for DCT and Remote Site Oversight Introduction to Decentralized Clinical Trials (DCT) and Remote Site Oversight As the clinical research landscape evolves, decentralized clinical trials (DCT) have emerged as a prominent model, facilitating patient participation and site management from a distance. This shift is particularly important for clinical trial researchers navigating the…

Read More “Regulatory Guidance Trends for DCT and Remote Site Oversight” »

Oversight of DCT/Hybrid Sites

Leveraging Patient Feedback to Strengthen DCT Oversight Models

Posted on By digi

Leveraging Patient Feedback to Strengthen DCT Oversight Models Leveraging Patient Feedback to Strengthen DCT Oversight Models In the ever-evolving landscape of clinical trials, particularly with the rise of decentralized trials (DCT), effective oversight has become a cornerstone of regulatory compliance and patient safety. As the demand for innovative solutions grows, understanding how to harness patient…

Read More “Leveraging Patient Feedback to Strengthen DCT Oversight Models” »

Oversight of DCT/Hybrid Sites

Aligning Audit Trails With ALCOA++ and Data Integrity Expectations

Posted on By digi

Aligning Audit Trails With ALCOA++ and Data Integrity Expectations Aligning Audit Trails With ALCOA++ and Data Integrity Expectations Introduction to Audit Trails in Clinical Trials In the context of clinical trials, maintaining data integrity is paramount. A critical aspect of ensuring data integrity is the management of audit trails, particularly in the realm of electronic…

Read More “Aligning Audit Trails With ALCOA++ and Data Integrity Expectations” »

Audit Trails & Access Controls

Using Automation and Analytics to Flag High-Risk Access Events

Posted on By digi

Using Automation and Analytics to Flag High-Risk Access Events Using Automation and Analytics to Flag High-Risk Access Events Introduction to High-Risk Access Events in Clinical Trials In clinical research, particularly in the context of the omomyc clinical trial, it is crucial to monitor and safeguard data integrity. As clinical trials have become increasingly complex, the…

Read More “Using Automation and Analytics to Flag High-Risk Access Events” »

Audit Trails & Access Controls

Estimands and Intercurrent Events in DCT, Rescue and Switch Designs

Posted on By digi

Estimands and Intercurrent Events in DCT, Rescue and Switch Designs Estimands and intercurrent events play a crucial role in the success of clinical trials, particularly in areas such as ulcerative colitis. This article serves as a comprehensive guide for clinical operations, regulatory affairs, and medical affairs professionals involved in clinical research in the US, UK,…

Read More “Estimands and Intercurrent Events in DCT, Rescue and Switch Designs” »

Estimands & Handling Intercurrent Events

Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny

Posted on By digi

Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny The emergence of decentralized clinical trials (DCTs) has propelled the entire clinical research ecosystem toward innovative methodologies for data collection, patient engagement, and regulatory compliance. The oversight of DCT and hybrid sites must be structured and thorough…

Read More “Case Studies: DCT Oversight Models That Passed Regulatory Scrutiny” »

Oversight of DCT/Hybrid Sites

Aligning DCT Oversight With RBM, KRIs and Signal Detection Tools

Posted on By digi

Aligning DCT Oversight With RBM, KRIs and Signal Detection Tools As the landscape of clinical trials evolves, the integration of decentralized clinical trials (DCT) presents new opportunities and challenges, particularly in terms of oversight. The application of Risk-Based Monitoring (RBM) methodologies, Key Risk Indicators (KRIs), and signal detection tools is becoming increasingly important. This tutorial…

Read More “Aligning DCT Oversight With RBM, KRIs and Signal Detection Tools” »

Oversight of DCT/Hybrid Sites

Case Studies: Audit Trail and Access Failures That Led to Findings

Posted on By digi

Case Studies: Audit Trail and Access Failures That Led to Findings Case Studies: Audit Trail and Access Failures That Led to Findings Clinical trials are governed by stringent regulations, ensuring the integrity and accuracy of data collected during the research process. Audit trails and access controls are essential components in maintaining compliance and ensuring data…

Read More “Case Studies: Audit Trail and Access Failures That Led to Findings” »

Audit Trails & Access Controls

Designing SOPs for Audit Trail Review and Access Control Governance

Posted on By digi

Designing SOPs for Audit Trail Review and Access Control Governance Designing SOPs for Audit Trail Review and Access Control Governance In the realm of clinical trials, especially as digital solutions increasingly dominate data management, establishing Standard Operating Procedures (SOPs) for audit trail review and access control governance is paramount. The need for robust data integrity…

Read More “Designing SOPs for Audit Trail Review and Access Control Governance” »

Audit Trails & Access Controls